Sen. Blackburn Introduces the Chloe Cole Act to Ban Gender-Affirming Care for Minors
The Chloe Cole Act is currently in the early stages of the legislative process. It was recently introduced in the Senate and sent to the Committee on Health, Education, Labor, and Pensions for review. There are no upcoming votes scheduled at this time.
This bill is a high-profile partisan effort that is unlikely to get the 60 votes needed to pass the Senate or gain support from the current administration.
Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
Transgender and gender-diverse minors would lose access to all medical transition care nationwide, including puberty blockers, hormone therapy, and surgery. This directly affects an estimated several thousand minors currently receiving such care and any future minors who might seek it. The bill also applies retroactively, potentially exposing the care history of past patients to legal proceedings.
“The use of puberty blockers, including gonadotropin releasing hormone agonists and other interventions, to delay the onset or progression of normally timed puberty in an individual.”
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in Senate
The bill was officially filed and given a number. It now enters the legislative queue.
The Chloe Cole Act is a key legislative priority for the administration. It would allow families to sue doctors who facilitate gender transitions for minors without parental consent or that cause 'irreparable harm.' Critics argue it could block necessary hormone therapy for various conditions.

Teaming up with detransitioner Chloe Cole, Rep. Bob Onder introduced federal legislation to block gender-related medical procedures for minors. The bill establishes a private right of action for those harmed by treatments like puberty blockers and cross-sex hormones.

The Chloe Cole Act of 2026 prohibits gender transition procedures for minors by regulating interstate commerce. It grants a private right of action with a statute of limitations expiring 25 years after the child turns 18, providing a legal deterrent against these procedures nationwide.
No votes recorded for this bill yet.
Document Type
Congressional Bill
Official Title
Chloe Cole Act
Analysis generated by AI. Always verify with official sources.